Jefferies Group’s Insmed INSM Stock Holding History

Jefferies Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-35,500	Closed	-$569K	–	1667
2020 Q1	$569K	Sell	35,500 -150,700	-81%	-$3.57M	0.01%	1267
2019 Q4	$4.45M	Buy	186,200 +137,200	+280%	+$2.79M	0.03%	576
2019 Q3	$864K	Hold	49,000	–	–	0.01%	1593
2019 Q2	$1.25M	Hold	49,000	–	–	0.01%	1170
2019 Q1	$1.42M	Hold	49,000	–	–	0.01%	1085
2018 Q4	$643K	Sell	49,000 -58,800	-55%	-$938K	0.01%	1367
2018 Q3	$2.18M	Buy	+107,800	New	+$2.43M	0.01%	933

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jefferies Group's INSM Position: Q3 2022 in Review

Jefferies Group opened a new position in Insmed (INSM) in Q3 2022: 28,550 shares worth $615K. The stake represents 0.01% of the portfolio and ranks #967 among its holdings. This is a return to the name: Jefferies Group previously reported a position in INSM as recently as Q1 2020.

Jefferies Group first reported a position in INSM in Q1 2014 and has held it in 12 quarters since. The position peaked at $3.46M in Q4 2019. 238 funds tracked by Wall St. Rank hold INSM as of Q3 2022.

Jefferies Group held 28,550 shares of Insmed worth $615K as of Q3 2022.
Insmed was a new Jefferies Group position in Q3 2022.
Insmed made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #967 holding.
Jefferies Group first reported a position in Insmed in Q1 2014 and has held it in 12 quarters since.
Jefferies Group's Insmed position peaked at $3.46M in Q4 2019.
238 funds tracked by Wall St. Rank held Insmed as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.